Safwan Saffour, Karim Gaber, Christoph Sippl, Bernardo Reyes, Stefan Linsler, Joachim Oertel
{"title":"Predictive Factors, Efficiency, and Outcomes of Radiofrequency Ablative Therapy for Sacroiliac Joint Syndrome: A Retrospective Study","authors":"Safwan Saffour, Karim Gaber, Christoph Sippl, Bernardo Reyes, Stefan Linsler, Joachim Oertel","doi":"10.1155/ane/4244669","DOIUrl":null,"url":null,"abstract":"<p><b>Introduction:</b> The sacroiliac joint (SIJ), despite limited mobility, plays a crucial role in load transfer and pelvic stability. As a true diarthrodial joint, it accounts for 15%–38% of low back pain cases. This study evaluated the clinical outcomes of radiofrequency ablation (RFA) for SIJ syndrome and examined predictors of treatment response.</p><p><b>Methods:</b> We retrospectively analyzed 101 patients treated with intra-articular RFA between 2017 and 2020. Pain and function were assessed using the Visual Analog Scale (VAS), Oswestry disability index (ODI), and McNab criteria.</p><p><b>Results:</b> The cohort (53.5% female, mean age 69.0 ± 14.2 years, BMI 28.18 ± 4.87) showed significant improvements in pain (VAS: 7.68 ± 1.4 to 2.6 ± 1.54 at 24 h, <i>p</i> < 0.001) and function (ODI: 57.5 ± 17.5 to 37.9 ± 16.97 at 12 months, <i>p</i> < 0.001). McNab scores improved from 2.36 ± 1.03 at 6 weeks to 3.32 ± 0.88 at 12 months (<i>p</i> < 0.001). Higher BMI was strongly associated with poorer outcomes (VAS <i>r</i> = 0.433–0.719, ODI <i>r</i> = 0.990, McNab <i>r</i> = –0.960 to –0.914; all <i>p</i> < 0.001). Prior spinal surgery affected short-term recovery but not long-term results.</p><p><b>Conclusion:</b> Intra-articular RFA is an effective treatment for SIJ syndrome, offering sustained pain relief and functional improvement up to 12 months. High BMI negatively impacts outcomes, highlighting the value of adjunctive strategies like weight management and rehabilitation to enhance long-term success.</p>","PeriodicalId":6939,"journal":{"name":"Acta Neurologica Scandinavica","volume":"2025 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ane/4244669","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neurologica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/ane/4244669","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The sacroiliac joint (SIJ), despite limited mobility, plays a crucial role in load transfer and pelvic stability. As a true diarthrodial joint, it accounts for 15%–38% of low back pain cases. This study evaluated the clinical outcomes of radiofrequency ablation (RFA) for SIJ syndrome and examined predictors of treatment response.
Methods: We retrospectively analyzed 101 patients treated with intra-articular RFA between 2017 and 2020. Pain and function were assessed using the Visual Analog Scale (VAS), Oswestry disability index (ODI), and McNab criteria.
Results: The cohort (53.5% female, mean age 69.0 ± 14.2 years, BMI 28.18 ± 4.87) showed significant improvements in pain (VAS: 7.68 ± 1.4 to 2.6 ± 1.54 at 24 h, p < 0.001) and function (ODI: 57.5 ± 17.5 to 37.9 ± 16.97 at 12 months, p < 0.001). McNab scores improved from 2.36 ± 1.03 at 6 weeks to 3.32 ± 0.88 at 12 months (p < 0.001). Higher BMI was strongly associated with poorer outcomes (VAS r = 0.433–0.719, ODI r = 0.990, McNab r = –0.960 to –0.914; all p < 0.001). Prior spinal surgery affected short-term recovery but not long-term results.
Conclusion: Intra-articular RFA is an effective treatment for SIJ syndrome, offering sustained pain relief and functional improvement up to 12 months. High BMI negatively impacts outcomes, highlighting the value of adjunctive strategies like weight management and rehabilitation to enhance long-term success.
期刊介绍:
Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience. The journal''s scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area. Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders. Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders. Priority will be given to review of topical subjects. Papers requiring rapid publication because of their significance and timeliness will be included as ''Clinical commentaries'' not exceeding two printed pages, as will ''Clinical commentaries'' of sufficient general interest. Debate within the speciality is encouraged in the form of ''Letters to the editor''. All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees.